title: The Relationship among COPD Severity, Inhaled Corticosteroid Use, and the Risk of Pneumonia.
authors.affiliation: 1 University of Nebraska Medical Center Omaha, Nebraska.
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Rennard
authors.affiliation: 2 University of British Columbia Vancouver, British Columbia, Canada.
authors.forename: Donald D
authors.initials: DD
authors.lastname: Sin
authors.affiliation: 3 David Geffen School of Medicine at the University of Los Angeles, California Los Angeles, California.
authors.forename: Donald P
authors.initials: DP
authors.lastname: Tashkin
authors.affiliation: 4 University of Liverpool Liverpool, United Kingdom.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Calverley
authors.affiliation: 5 Skane University Hospital Lund, Sweden.
authors.forename: Finn
authors.initials: F
authors.lastname: Radner
mesh_terms: D000280:Administration, Inhalation; D019819:Budesonide / Q000008:administration & dosage* / Q000009:adverse effects*; D000068759:Formoterol Fumarate / Q000627:therapeutic use; D006801:Humans; D011014:Pneumonia / Q000453:epidemiology*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012720:Severity of Illness Index
chemical_list: D019819:Budesonide; D000068759:Formoterol Fumarate